Sort
10,829 grants matching “car t”
Hematologic Malignancies
$55,542Ronald Levy · Stanford University · P30 · FY2024 · CA
Hematologic Malignancies
$55,390Stephen J Forma · Beckman Research Institute/City Of Hope · P30 · FY2019 · CA
NGTC - INSERM
$55,041Emmanuel Donnadieu · Inserm Paris 5 · OT2 · FY2023 · CA
A wearable Device for Continuous Monitoring of Methadone
$55,000Farshad Tehrani · Actiox Llc · R43 · FY2024 · DA
Olera - Online Platform to Increase Access to Personalized Educational and Professional Assistance for AD/ADRD Caregivers
$55,000Tokunbo Falohun · Olera Inc. · R44 · FY2022 · AG
A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressed
$55,000Maria Constance Athanasiou · Marpam Pharma, Llc · R42 · FY2023 · AI
TOPIC 429 - A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING (SBIR)
$55,000Bob Snyder · Proteios Technology, Inc. · N43 · FY2022 · CA
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
$55,000Matthew James Spindler · Gigamune, Inc. · R43 · FY2023 · AI
Chimeric antigen receptor-modified iNKT cell therapy for CD7+ malignancies
$55,000Xianzheng Zhou · Tinkeso Therapeutics Inc · R43 · FY2024 · CA
Intelligent Biometrics to Optimize Prolonged Exposure Treatment for PTSD (IB-PE)
$55,000William Harley · Zeriscope, Inc. · R43 · FY2020 · MH
Developing novel therapeutics for the treatment of mastocytosis
$55,000Jianya Peng · Nemagen Discoveries, Inc · R43 · FY2023 · TR
Simple and Effective Method for Cell Enrichment and Cell Depletion During Cell Therapy
$55,000Bob Snyder · Proteios Technology, Inc. · R43 · FY2020 · GM
IGF::OT::IGF Topic 372: Development and Validation of Canine scFvs for Pre-Clinical Development of Targeted Therapeutics - Moonshot
$54,994Brendan Pucell · Vetigenics Llc · N43 · FY2019 · CA
Functional consequences of high glucose culture on adoptive T cell therapies for cancer
$54,538Hannah Bumgarner · University Of Pittsburgh At Pittsburgh · F30 · FY2025 · CA
Development of Tunable Microenvironment-Responsive CAR T Cells Using Synthetic Gene Circuits to Enhance Potency and Safety
$54,538Yannick Rene Schreiber · Northwestern University · F30 · FY2025 · CA
Engineering detours around the biologic barriers to allogeneic, iPSC-derived CAR T immunotherapy
$54,538Sang Pil Yoo · University Of California Los Angeles · F30 · FY2025 · CA
Investigating the role of BAFF in CAR-T cell associated adverse events
$54,538Claire Fritz · Case Western Reserve University · F30 · FY2025 · CA
Identification of genes that limit CAR T persistence in solid tumors
$54,538Robert Hapke · University Of Pennsylvania · F30 · FY2025 · CA
ICOS is an important mediator of both resident memory cell formation, and improved durability and persistence of anti-tumor T cells
$54,538Megen Claire Wittling · Emory University · F30 · FY2025 · CA
Chimeric Antigen Receptor Myeloid Cells for Alzheimer's Disease Therapy
$54,437Alexander Kim · Washington University · F30 · FY2025 · AG
CARS Imaging for Studies of Cell Metabolism
$54,352Harvard University · F33 · FY2002 · GM
Text-Based mHealth for Emergency department patients with Diabetes (TExT-MED)
$54,033Elizabeth Rhea Erwin Burner · University Of Southern California · F32 · FY2012 · DK
Randomized controlled trial to evaluate the effect of a novel web-based intervent
$54,000Magaly Marlitz Blas · Universidad Peruana Cayetano Heredia · R01 · FY2010 · TW
Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell Therapy
$54,000Sara Barmettler · Massachusetts General Hospital · K23 · FY2022 · AI
Prenatal Opioid Exposure and Inflammation: The Role of the Microbiome and Epigenome.
$53,974Yaa Abu · University Of Miami School Of Medicine · F31 · FY2024 · DA